Literature DB >> 9463477

Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.

S Lankiewicz1, N Lobitz, C H Wetzel, R Rupprecht, G Gisselmann, H Hatt.   

Abstract

Polymerase chain reaction and rapid amplification of cDNA ends were used to isolate cDNAs encoding a 5-hydroxytryptamine3 (5-HT3) receptor subunit and its splice variants from guinea pig intestine. The amino acid sequence predicted from this cDNA is 81% homologous to the murine 5-HT3 receptor subunits cloned from NCB20 and N1E-115 cells. The splice variants code for two proteins differing by a deletion of six amino acids located in the large intracellular loop between transmembrane domains M3 and M4. For characterization, the cloned 5-HT3 cDNA was expressed in HEK 293 cells, and the electrophysiological and pharmacological properties of the recombinant ion/channel/receptor complex were investigated by patch clamping. Our data reveal that the cloned cDNAs code for guinea pig 5-HT3 receptors, which functionally assemble as homo-oligomers. The kinetic behavior of the ion channel and its sensitivity to several agonists and antagonists were markedly different from those of the cloned 5-HT3 receptors from mouse and human under similar experimental conditions. The agonists used were 5-hydroxytryptamine, 2-methyl-5-hydroxytryptamine, 1-phenylbiguanide (PBG), m-chlorophenylbiguanide, and the antagonists tropisetron and metoclopramide. In addition, 5-HT, PBG, and tropisetron were investigated through radioligand binding to isolated membranes. Compared with the human and murine 5-HT3 receptors, the guinea pig receptor showed prolonged desensitization kinetics. In addition, the guinea pig 5-HT3 receptor did not respond to the selective 5-HT3 receptor agonist PBG. Construction of chimeric receptors between guinea pig and human 5-HT3 receptor sequences localized the differences in desensitization kinetics to the carboxyl-terminal domain and the ligand binding site to the amino-terminal domain of the receptor protein. Molecular determinants of the PBG binding site of the human 5-HT3 receptor were localized to a 28-amino-acid spanning region adjacent to the M1 region.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463477     DOI: 10.1124/mol.53.2.202

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

1.  The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.

Authors:  M J Gunthorpe; J A Peters; C H Gill; J J Lambert; S C Lummis
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

2.  Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.

Authors:  G Hapfelmeier; C Tredt; R Haseneder; W Zieglgänsberger; B Eisensamer; R Rupprecht; G Rammes
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

3.  Serotonin 5-HT(3) receptors in rat CA1 hippocampal interneurons: functional and molecular characterization.

Authors:  Sterling N Sudweeks; Johannes A van Hooft; Jerrel L Yakel
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

4.  Electrical interfacing of neurotransmitter receptor and field effect transistor.

Authors:  I Peitz; P Fromherza
Journal:  Eur Phys J E Soft Matter       Date:  2009-10       Impact factor: 1.890

Review 5.  Targeting peripheral afferent nerve terminals for cough and dyspnea.

Authors:  Yukiko Muroi; Bradley J Undem
Journal:  Curr Opin Pharmacol       Date:  2011-06-24       Impact factor: 5.547

Review 6.  Vagal Afferent Innervation of the Airways in Health and Disease.

Authors:  Stuart B Mazzone; Bradley J Undem
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

7.  Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.

Authors:  Jan Walkembach; Michael Brüss; Bernd W Urban; Martin Barann
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

8.  Tyrosine residues that control binding and gating in the 5-hydroxytryptamine3 receptor revealed by unnatural amino acid mutagenesis.

Authors:  Darren L Beene; Kerry L Price; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

Review 9.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

10.  Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.

Authors:  Xiang-Qun Hu
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.